Global Human Vaccine Market Growth 2020-2025
According to this study, over the next five years the Human Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Human Vaccine, covering the supply chain analysis, impact assessment to the Human Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Human Vaccine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CNBG
SANOFI
Changsheng Life
ChengDa Bio
Kangtai
Zhifei
Walvax Biotechnology
SINOVAC BIOTECH
GSK
Hissen
Adimmune
Zhongyianke Biotech
Rong An
Tiantan biological
Hualan Bio
Changchun Baike
NuoCheng Bio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Vaccine market by identifying its various subsegments.
Focuses on the key global Human Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Vaccine Consumption 2015-2025
2.1.2 Human Vaccine Consumption CAGR by Region
2.2 Human Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Rota vaccine
2.3 Human Vaccine Consumption by Type
2.3.1 Global Human Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Vaccine Sale Price by Type (2015-2020)
2.4 Human Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccine Consumption by Application
2.5.1 Global Human Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Human Vaccine Sale Price by Type (2015-2020)
3 Global Human Vaccine by Company
3.1 Global Human Vaccine Sales Market Share by Company
3.1.1 Global Human Vaccine Sales by Company (2018-2020)
3.1.2 Global Human Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Human Vaccine Revenue Market Share by Company
3.2.1 Global Human Vaccine Revenue by Company (2018-2020)
3.2.2 Global Human Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Human Vaccine Sale Price by Company
3.4 Global Human Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Vaccine by Regions
4.1 Human Vaccine by Regions
4.2 Americas Human Vaccine Consumption Growth
4.3 APAC Human Vaccine Consumption Growth
4.4 Europe Human Vaccine Consumption Growth
4.5 Middle East & Africa Human Vaccine Consumption Growth
5 Americas
5.1 Americas Human Vaccine Consumption by Countries
5.1.1 Americas Human Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Human Vaccine Value by Countries (2015-2020)
5.2 Americas Human Vaccine Consumption by Type
5.3 Americas Human Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Vaccine Consumption by Regions
6.1.1 APAC Human Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Human Vaccine Value by Regions (2015-2020)
6.2 APAC Human Vaccine Consumption by Type
6.3 APAC Human Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Human Vaccine by Countries
7.1.1 Europe Human Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Human Vaccine Value by Countries (2015-2020)
7.2 Europe Human Vaccine Consumption by Type
7.3 Europe Human Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Vaccine by Countries
8.1.1 Middle East & Africa Human Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Human Vaccine Consumption by Type
8.3 Middle East & Africa Human Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Vaccine Distributors
10.3 Human Vaccine Customer
11 Global Human Vaccine Market Forecast
11.1 Global Human Vaccine Consumption Forecast (2021-2025)
11.2 Global Human Vaccine Forecast by Regions
11.2.1 Global Human Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Human Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Vaccine Forecast by Type
11.8 Global Human Vaccine Forecast by Application
12 Key Players Analysis
12.1 CNBG
12.1.1 Company Information
12.1.2 Human Vaccine Product Offered
12.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CNBG Latest Developments
12.2 SANOFI
12.2.1 Company Information
12.2.2 Human Vaccine Product Offered
12.2.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 SANOFI Latest Developments
12.3 Changsheng Life
12.3.1 Company Information
12.3.2 Human Vaccine Product Offered
12.3.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Changsheng Life Latest Developments
12.4 ChengDa Bio
12.4.1 Company Information
12.4.2 Human Vaccine Product Offered
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ChengDa Bio Latest Developments
12.5 Kangtai
12.5.1 Company Information
12.5.2 Human Vaccine Product Offered
12.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kangtai Latest Developments
12.6 Zhifei
12.6.1 Company Information
12.6.2 Human Vaccine Product Offered
12.6.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zhifei Latest Developments
12.7 Walvax Biotechnology
12.7.1 Company Information
12.7.2 Human Vaccine Product Offered
12.7.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Walvax Biotechnology Latest Developments
12.8 SINOVAC BIOTECH
12.8.1 Company Information
12.8.2 Human Vaccine Product Offered
12.8.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SINOVAC BIOTECH Latest Developments
12.9 GSK
12.9.1 Company Information
12.9.2 Human Vaccine Product Offered
12.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GSK Latest Developments
12.10 Hissen
12.10.1 Company Information
12.10.2 Human Vaccine Product Offered
12.10.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hissen Latest Developments
12.11 Adimmune
12.11.1 Company Information
12.11.2 Human Vaccine Product Offered
12.11.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Adimmune Latest Developments
12.12 Zhongyianke Biotech
12.12.1 Company Information
12.12.2 Human Vaccine Product Offered
12.12.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Zhongyianke Biotech Latest Developments
12.13 Rong An
12.13.1 Company Information
12.13.2 Human Vaccine Product Offered
12.13.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Rong An Latest Developments
12.14 Tiantan biological
12.14.1 Company Information
12.14.2 Human Vaccine Product Offered
12.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Tiantan biological Latest Developments
12.15 Hualan Bio
12.15.1 Company Information
12.15.2 Human Vaccine Product Offered
12.15.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hualan Bio Latest Developments
12.16 Changchun Baike
12.16.1 Company Information
12.16.2 Human Vaccine Product Offered
12.16.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Changchun Baike Latest Developments
12.17 NuoCheng Bio
12.17.1 Company Information
12.17.2 Human Vaccine Product Offered
12.17.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 NuoCheng Bio Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Varicella
Table 5. Major Players of Influenza
Table 6. Major Players of Polio
Table 7. Major Players of Hepatitis A
Table 8. Major Players of Rabies
Table 9. Major Players of BCG
Table 10. Major Players of Hepatitis B
Table 11. Major Players of Pertussis, Diphtheria, Tetanus
Table 12. Major Players of Pneumococcal
Table 13. Major Players of Rota vaccine
Table 14. Global Consumption Sales by Type (2015-2020)
Table 15. Global Human Vaccine Consumption Market Share by Type (2015-2020)
Table 16. Global Human Vaccine Revenue by Type (2015-2020) ($ million)
Table 17. Global Human Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 18. Global Human Vaccine Sale Price by Type (2015-2020)
Table 19. Global Consumption Sales by Application (2015-2020)
Table 20. Global Human Vaccine Consumption Market Share by Application (2015-2020)
Table 21. Global Human Vaccine Value by Application (2015-2020)
Table 22. Global Human Vaccine Value Market Share by Application (2015-2020)
Table 23. Global Human Vaccine Sale Price by Application (2015-2020)
Table 24. Global Human Vaccine Sales by Company (2017-2019) (M Doses)
Table 25. Global Human Vaccine Sales Market Share by Company (2017-2019)
Table 26. Global Human Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 27. Global Human Vaccine Revenue Market Share by Company (2017-2019)
Table 28. Global Human Vaccine Sale Price by Company (2017-2019)
Table 29. Global Human Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 30. Players Human Vaccine Products Offered
Table 31. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 32. Global Human Vaccine Consumption by Regions 2015-2020 (M Doses)
Table 33. Global Human Vaccine Consumption Market Share by Regions 2015-2020
Table 34. Global Human Vaccine Value by Regions 2015-2020 ($ Millions)
Table 35. Global Human Vaccine Value Market Share by Regions 2015-2020
Table 36. Americas Human Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 37. Americas Human Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. Americas Human Vaccine Value by Countries (2015-2020) ($ Millions)
Table 39. Americas Human Vaccine Value Market Share by Countries (2015-2020)
Table 40. Americas Human Vaccine Consumption by Type (2015-2020) (M Doses)
Table 41. Americas Human Vaccine Consumption Market Share by Type (2015-2020)
Table 42. Americas Human Vaccine Consumption by Application (2015-2020) (M Doses)
Table 43. Americas Human Vaccine Consumption Market Share by Application (2015-2020)
Table 44. APAC Human Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 45. APAC Human Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. APAC Human Vaccine Value by Regions (2015-2020) ($ Millions)
Table 47. APAC Human Vaccine Value Market Share by Regions (2015-2020)
Table 48. APAC Human Vaccine Consumption by Type (2015-2020) (M Doses)
Table 49. APAC Human Vaccine Consumption Market Share by Type (2015-2020)
Table 50. APAC Human Vaccine Consumption by Application (2015-2020) (M Doses)
Table 51. APAC Human Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Europe Human Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 53. Europe Human Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Europe Human Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Europe Human Vaccine Value Market Share by Countries (2015-2020)
Table 56. Europe Human Vaccine Consumption by Type (2015-2020) (M Doses)
Table 57. Europe Human Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Europe Human Vaccine Consumption by Application (2015-2020) (M Doses)
Table 59. Europe Human Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Middle East & Africa Human Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 61. Middle East & Africa Human Vaccine Consumption Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Human Vaccine Value by Countries (2015-2020) ($ Millions)
Table 63. Middle East & Africa Human Vaccine Value Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Human Vaccine Consumption by Type (2015-2020) (M Doses)
Table 65. Middle East & Africa Human Vaccine Consumption Market Share by Type (2015-2020)
Table 66. Middle East & Africa Human Vaccine Consumption by Application (2015-2020) (M Doses)
Table 67. Middle East & Africa Human Vaccine Consumption Market Share by Application (2015-2020)
Table 68. Human Vaccine Distributors List
Table 69. Human Vaccine Customer List
Table 70. Global Human Vaccine Consumption Forecast by Countries (2021-2025) (M Doses)
Table 71. Global Human Vaccine Consumption Market Forecast by Regions
Table 72. Global Human Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 73. Global Human Vaccine Value Market Share Forecast by Regions
Table 74. Global Human Vaccine Consumption Forecast by Type (2021-2025) (M Doses)
Table 75. Global Human Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 76. Global Human Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 77. Global Human Vaccine Value Market Share Forecast by Type (2021-2025)
Table 78. Global Human Vaccine Consumption Forecast by Application (2021-2025) (M Doses)
Table 79. Global Human Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 80. Global Human Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 81. Global Human Vaccine Value Market Share Forecast by Application (2021-2025)
Table 82. CNBG Product Offered
Table 83. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 84. CNBG Main Business
Table 85. CNBG Latest Developments
Table 86. CNBG Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. SANOFI Product Offered
Table 88. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 89. SANOFI Main Business
Table 90. SANOFI Latest Developments
Table 91. SANOFI Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Changsheng Life Product Offered
Table 93. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 94. Changsheng Life Main Business
Table 95. Changsheng Life Latest Developments
Table 96. Changsheng Life Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. ChengDa Bio Product Offered
Table 98. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 99. ChengDa Bio Main Business
Table 100. ChengDa Bio Latest Developments
Table 101. ChengDa Bio Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Kangtai Product Offered
Table 103. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 104. Kangtai Main Business
Table 105. Kangtai Latest Developments
Table 106. Kangtai Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Zhifei Product Offered
Table 108. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 109. Zhifei Main Business
Table 110. Zhifei Latest Developments
Table 111. Zhifei Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Walvax Biotechnology Product Offered
Table 113. Walvax Biotechnology Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Walvax Biotechnology Main Business
Table 115. Walvax Biotechnology Latest Developments
Table 116. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 117. SINOVAC BIOTECH Product Offered
Table 118. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 119. SINOVAC BIOTECH Main Business
Table 120. SINOVAC BIOTECH Latest Developments
Table 121. SINOVAC BIOTECH Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. GSK Product Offered
Table 123. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 124. GSK Main Business
Table 125. GSK Latest Developments
Table 126. GSK Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Hissen Product Offered
Table 128. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 129. Hissen Main Business
Table 130. Hissen Latest Developments
Table 131. Hissen Basic Information, Company Total Revenue (in $ million), Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. Adimmune Product Offered
Table 133. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 134. Adimmune Main Business
Table 135. Adimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Adimmune Latest Developments
Table 137. Zhongyianke Biotech Product Offered
Table 138. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 139. Zhongyianke Biotech Main Business
Table 140. Zhongyianke Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Zhongyianke Biotech Latest Developments
Table 142. Rong An Product Offered
Table 143. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 144. Rong An Main Business
Table 145. Rong An Latest Developments
Table 146. Rong An Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Tiantan biological Product Offered
Table 148. Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 149. Tiantan biological Main Business
Table 150. Tiantan biological Latest Developments
Table 151. Tiantan biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 152. Hualan Bio Product Offered
Table 153. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 154. Hualan Bio Main Business
Table 155. Hualan Bio Latest Developments
Table 156. Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 157. Changchun Baike Product Offered
Table 158. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 159. Changchun Baike Main Business
Table 160. Changchun Baike Latest Developments
Table 161. Changchun Baike Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 162. NuoCheng Bio Product Offered
Table 163. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 164. NuoCheng Bio Main Business
Table 165. NuoCheng Bio Latest Developments
Table 166. NuoCheng Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Human Vaccine
Figure 2. Human Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Vaccine Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Human Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Varicella
Figure 7. Product Picture of Influenza
Figure 8. Product Picture of Polio
Figure 9. Product Picture of Hepatitis A
Figure 10. Product Picture of Rabies
Figure 11. Product Picture of BCG
Figure 12. Product Picture of Hepatitis B
Figure 13. Product Picture of Pertussis, Diphtheria, Tetanus
Figure 14. Product Picture of Pneumococcal
Figure 15. Product Picture of Rota vaccine
Figure 16. Global Human Vaccine Consumption Market Share by Type (2015-2020)
Figure 17. Global Human Vaccine Value Market Share by Type (2015-2020)
Figure 18. Human Vaccine Consumed in Adults
Figure 19. Global Human Vaccine Market: Adults (2015-2020) (M Doses)
Figure 20. Global Human Vaccine Market: Adults (2015-2020) ($ Millions)
Figure 21. Human Vaccine Consumed in Children
Figure 22. Global Human Vaccine Market: Children (2015-2020) (M Doses)
Figure 23. Global Human Vaccine Market: Children (2015-2020) ($ Millions)
Figure 24. Global Human Vaccine Consumption Market Share by Application (2015-2020)
Figure 25. Global Human Vaccine Value Market Share by Application (2015-2020)
Figure 26. Global Human Vaccine Sales Market Share by Company in 2017
Figure 27. Global Human Vaccine Sales Market Share by Company in 2019
Figure 28. Global Human Vaccine Revenue Market Share by Company in 2017
Figure 29. Global Human Vaccine Revenue Market Share by Company in 2019
Figure 30. Global Human Vaccine Sale Price by Company in 2019
Figure 31. Global Human Vaccine Consumption Market Share by Regions 2015-2020
Figure 32. Global Human Vaccine Value Market Share by Regions 2015-2020
Figure 33. Americas Human Vaccine Consumption 2015-2020 (M Doses)
Figure 34. Americas Human Vaccine Value 2015-2020 ($ Millions)
Figure 35. APAC Human Vaccine Consumption 2015-2020 (M Doses)
Figure 36. APAC Human Vaccine Value 2015-2020 ($ Millions)
Figure 37. Europe Human Vaccine Consumption 2015-2020 (M Doses)
Figure 38. Europe Human Vaccine Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Human Vaccine Consumption 2015-2020 (M Doses)
Figure 40. Middle East & Africa Human Vaccine Value 2015-2020 ($ Millions)
Figure 41. Americas Human Vaccine Consumption Market Share by Countries in 2019
Figure 42. Americas Human Vaccine Value Market Share by Countries in 2019
Figure 43. Americas Human Vaccine Consumption Market Share by Type in 2019
Figure 44. Americas Human Vaccine Consumption Market Share by Application in 2019
Figure 45. United States Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 46. United States Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 48. Canada Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 50. Mexico Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Human Vaccine Consumption Market Share by Countries in 2019
Figure 52. APAC Human Vaccine Value Market Share by Regions in 2019
Figure 53. APAC Human Vaccine Consumption Market Share by Type in 2019
Figure 54. APAC Human Vaccine Consumption Market Share by Application in 2019
Figure 55. China Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 56. China Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 58. Japan Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 60. Korea Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 62. Southeast Asia Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 63. India Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 64. India Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 66. Australia Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Human Vaccine Consumption Market Share by Countries in 2019
Figure 68. Europe Human Vaccine Value Market Share by Countries in 2019
Figure 69. Europe Human Vaccine Consumption Market Share by Type in 2019
Figure 70. Europe Human Vaccine Consumption Market Share by Application in 2019
Figure 71. Germany Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 72. Germany Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. France Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 74. France Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 75. UK Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 76. UK Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 78. Italy Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 80. Russia Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Human Vaccine Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Human Vaccine Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Human Vaccine Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Human Vaccine Consumption Market Share by Application in 2019
Figure 85. Egypt Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 86. Egypt Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 88. South Africa Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 90. Israel Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 92. Turkey Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Human Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 94. GCC Countries Human Vaccine Value Growth 2015-2020 ($ Millions)
Figure 95. Global Human Vaccine Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 96. Global Human Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Human Vaccine Consumption 2021-2025 (M Doses)
Figure 98. Americas Human Vaccine Value 2021-2025 ($ Millions)
Figure 99. APAC Human Vaccine Consumption 2021-2025 (M Doses)
Figure 100. APAC Human Vaccine Value 2021-2025 ($ Millions)
Figure 101. Europe Human Vaccine Consumption 2021-2025 (M Doses)
Figure 102. Europe Human Vaccine Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Human Vaccine Consumption 2021-2025 (M Doses)
Figure 104. Middle East & Africa Human Vaccine Value 2021-2025 ($ Millions)
Figure 105. United States Human Vaccine Consumption 2021-2025 (M Doses)
Figure 106. United States Human Vaccine Value 2021-2025 ($ Millions)
Figure 107. Canada Human Vaccine Consumption 2021-2025 (M Doses)
Figure 108. Canada Human Vaccine Value 2021-2025 ($ Millions)
Figure 109. Mexico Human Vaccine Consumption 2021-2025 (M Doses)
Figure 110. Mexico Human Vaccine Value 2021-2025 ($ Millions)
Figure 111. Brazil Human Vaccine Consumption 2021-2025 (M Doses)
Figure 112. Brazil Human Vaccine Value 2021-2025 ($ Millions)
Figure 113. China Human Vaccine Consumption 2021-2025 (M Doses)
Figure 114. China Human Vaccine Value 2021-2025 ($ Millions)
Figure 115. Japan Human Vaccine Consumption 2021-2025 (M Doses)
Figure 116. Japan Human Vaccine Value 2021-2025 ($ Millions)
Figure 117. Korea Human Vaccine Consumption 2021-2025 (M Doses)
Figure 118. Korea Human Vaccine Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Human Vaccine Consumption 2021-2025 (M Doses)
Figure 120. Southeast Asia Human Vaccine Value 2021-2025 ($ Millions)
Figure 121. India Human Vaccine Consumption 2021-2025 (M Doses)
Figure 122. India Human Vaccine Value 2021-2025 ($ Millions)
Figure 123. Australia Human Vaccine Consumption 2021-2025 (M Doses)
Figure 124. Australia Human Vaccine Value 2021-2025 ($ Millions)
Figure 125. Germany Human Vaccine Consumption 2021-2025 (M Doses)
Figure 126. Germany Human Vaccine Value 2021-2025 ($ Millions)
Figure 127. France Human Vaccine Consumption 2021-2025 (M Doses)
Figure 128. France Human Vaccine Value 2021-2025 ($ Millions)
Figure 129. UK Human Vaccine Consumption 2021-2025 (M Doses)
Figure 130. UK Human Vaccine Value 2021-2025 ($ Millions)
Figure 131. Italy Human Vaccine Consumption 2021-2025 (M Doses)
Figure 132. Italy Human Vaccine Value 2021-2025 ($ Millions)
Figure 133. Russia Human Vaccine Consumption 2021-2025 (M Doses)
Figure 134. Russia Human Vaccine Value 2021-2025 ($ Millions)
Figure 135. Spain Human Vaccine Consumption 2021-2025 (M Doses)
Figure 136. Spain Human Vaccine Value 2021-2025 ($ Millions)
Figure 137. Egypt Human Vaccine Consumption 2021-2025 (M Doses)
Figure 138. Egypt Human Vaccine Value 2021-2025 ($ Millions)
Figure 139. South Africa Human Vaccine Consumption 2021-2025 (M Doses)
Figure 140. South Africa Human Vaccine Value 2021-2025 ($ Millions)
Figure 141. Israel Human Vaccine Consumption 2021-2025 (M Doses)
Figure 142. Israel Human Vaccine Value 2021-2025 ($ Millions)
Figure 143. Turkey Human Vaccine Consumption 2021-2025 (M Doses)
Figure 144. Turkey Human Vaccine Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Human Vaccine Consumption 2021-2025 (M Doses)
Figure 146. GCC Countries Human Vaccine Value 2021-2025 ($ Millions)
Figure 147. CNBG Human Vaccine Market Share (2018-2020)
Figure 148. SANOFI Human Vaccine Market Share (2018-2020)
Figure 149. Changsheng Life Human Vaccine Market Share (2018-2020)
Figure 150. ChengDa Bio Human Vaccine Market Share (2018-2020)
Figure 151. Kangtai Human Vaccine Market Share (2018-2020)
Figure 152. Zhifei Human Vaccine Market Share (2018-2020)
Figure 153. Walvax Biotechnology Human Vaccine Market Share (2018-2020)
Figure 154. SINOVAC BIOTECH Human Vaccine Market Share (2018-2020)
Figure 155. GSK Human Vaccine Market Share (2018-2020)
Figure 156. Hissen Human Vaccine Market Share (2018-2020)
Figure 157. Adimmune Human Vaccine Market Share (2018-2020)
Figure 158. Zhongyianke Biotech Human Vaccine Market Share (2018-2020)
Figure 159. Rong An Human Vaccine Market Share (2018-2020)
Figure 160. Tiantan biological Human Vaccine Market Share (2018-2020)
Figure 161. Hualan Bio Human Vaccine Market Share (2018-2020)
Figure 162. Changchun Baike Human Vaccine Market Share (2018-2020)
Figure 163. NuoCheng Bio Human Vaccine Market Share (2018-2020)
